Long-term immunogenicity and efficacy of a recombinant hepatitis B vaccine in Egyptian children

I H el-Sawy1, O N Mohamed

  • 1Department of Paediatrics, Faculty of Medicine, University of Alexandria, Egypt.

Insights

Egypt's hepatitis B vaccine schedule shows low long-term protection. A new 1, 2, and 9-month schedule and booster doses are recommended for sustained immunity.

Area of Science:

  • Immunology
  • Vaccinology
  • Public Health

Background:

  • Egypt implemented a universal hepatitis B vaccination program in 1992.
  • The national schedule involved vaccine administration at 2, 4, and 6 months of age.

Purpose of the Study:

  • To assess the long-term immunogenicity and efficacy of the hepatitis B vaccine schedule used in Egypt.
  • To evaluate antibody concentrations and seroprotection rates in children vaccinated at different time points.

Main Methods:

  • A cohort of 180 children vaccinated with the hepatitis B vaccine (2, 4, 6 months schedule) was studied.
  • Participants' time since last vaccination ranged from 1 month to 5 years.
  • Hepatitis B surface antigen (HBsAg), anti-hepatitis B core (anti-HBc), and anti-hepatitis B surface (anti-HBs) antibody levels were measured.

Main Results:

  • A high seroprotection rate (93.3%) was observed shortly after vaccination.
  • However, initial anti-HBs concentrations were low and declined rapidly over time.
  • No participants exhibited clinical hepatitis or HBsAg, and most had negative anti-HBc results.

Conclusions:

  • The 2-month interval between the second and third hepatitis B vaccine doses may compromise long-term immunity.
  • Booster vaccinations are recommended for all previously vaccinated children.
  • A revised vaccination schedule (1, 2, and 9 months) is proposed for improved long-term protection.

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...